Gland Pharma Limited
GLAND
Classifica tra le azioni
#3230
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Prezzo delle azioni
$33.27
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$5.49B
Variazione (1 giorno)
-0.85%
Variazione (1 anno)
51.89%
Paese
IN
Scambia Gland Pharma Limited (GLAND)
Categoria
Healthcare
EPS per Gland Pharma Limited (GLAND)
EPS al June 2026 TTM: $0.76
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Gland Pharma Limited, l’EPS attuale della società (TTM) è $0.76. Alla fine del 2024, la società aveva un EPS di $0.56 una diminuzione rispetto a rispetto a quello del 2023, che era di $0.58.
Storico EPS per Gland Pharma Limited da 2017 a 2026
EPS alla fine di ogni anno
| Anno | EPS | Cambia |
|---|---|---|
| 2026 (TTM) | $0.76 | 51.22% |
| 2025 | $0.50 | -11.86% |
| 2024 | $0.56 | -2.56% |
| 2023 | $0.58 | -40.63% |
| 2022 | $0.97 | 12.85% |
| 2021 | $0.86 | 30.13% |
| 2020 | $0.66 | 57.68% |
| 2019 | $0.42 | 31.96% |
| 2018 | $0.32 | -22.71% |
| 2017 | $0.41 | 0.00% |
EPS per aziende simili o concorrenti
| Azienda | EPS | Differenza di EPS | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -26.43% |
IN
|
